1. Akutsu Y, Shinozuka A, Huang TY, Watanabe T, Yamada T, Yamanaka H, et al. Hypertrophic cardiomyopathy with apical left ventricular aneurysm. Jpn Circ J. 1988. 62:127–131.
Article
2. Lin CS, Chen CH, Ding PY. Apical hypertrophic cardiomyopathy mimicking acute myocardial infarction. Int J Cardiol. 1998. 64:305–307.
Article
3. Harada K, Shimizu T, Sugishita Y, Yao A, Suzuki J, Takenaka K, et al. Hypertrophic cardiomyopathy with midventricular obstruction and apical aneurysm: a case report. Jpn Circ J. 2001. 65:915–919.
Article
4. Ito N, Suzuki M, Enjoji Y, Nakamura M, Namiki A, Hase H, et al. Hypertrophic cardiomyopathy with mid-ventricular obstruction complicated with apical left ventricular aneurysm and ventricular tachycardia: a case report. J Cardiol. 2002. 39:213–219.
5. Tse HF, Ho HH. Sudden cardiac death caused by hypertrophic cardiomyopathy associated with midventricular obstruction and apical aneurysm. Heart. 2003. 89:178.
Article
6. Tengiz I, Ercan E, Türk UO. Percutaneous myocardial ablation for left mid-ventricular obstructive hypertrophic cardiomyopathy. Int J Cardiovasc Imaging. 2006. 22:13–18.
Article
7. Matsubara K, Nakamura T, Kuribayashi T, Azuma A, Nakagawa M. Sustained cavity obliteration and apical aneurysm formation in apical hypertrophic cardiomyopathy. J Am Coll Cardiol. 2003. 42:288–295.
Article
8. Maron BJ, Hauser RG, Roberts WC. Hypertrophic cardiomyopathy with left ventricular apical diverticulum. Am J Cardiol. 1999. 77:1263–1265.
Article
9. Ward RP, Pokharna HK, Lang RM, Williams KA. Resting "Solar Polar" map pattern and reduced apical flow reserve: characteristics of apical hypertrophic cardiomyopathy on SPECT myocardial perfusion imaging. J Nucl Cardiol. 2003. 10:506–512.
Article
10. Fighali S, Krajcer Z, Edelman S, Leachman RD. Progression of hypertrophic cardiomyopathy into a hypokinetic left ventricle: higher incidence in patients with midventricular obstruction. J Am Coll Cardiol. 1987. 9:288–294.
Article
11. Nakamura T, Matsubara K, Furukawa K, Azuma A, Sugihara H, Katsume H, et al. Diastolic paradoxic jet flow in patients with hypertrophic cardiomyopathy: evidence of concealed apical asynergy with cavity obliteration. J Am Coll Cardiol. 1992. 19:516–524.
Article
12. Maron BJ, Casey SA, Poliac LC, Gohman TE, Almquist AK, Aeppli DM. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. JAMA. 1999. 281:650–655.
Article
13. Maron BJ, Nishimura RA, McKenna WJ, Rakowski H, Josephson ME, Kieval RS. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY). Circulation. 1999. 99:2927–2933.
Article
14. Watanabe H, Kibira S, Saito T, Shimizu H, Abe T, Nakajima I, et al. Beneficial effect of dual-chamber pacing for a left mid-ventricular obstruction with apical aneurysm. Circ J. 2002. 66:981–984.
Article
15. Seggewiss H, Faber L. Percutaneous septal ablation for hypertrophic cardiomyopathy and mid-ventricular obstruction. Eur J Echocardiogr. 2000. 1:277–280.
Article